Zobrazeno 1 - 10
of 179
pro vyhledávání: '"B, Somoza"'
Autor:
M. Sanz-Gómez, F.J. Manzano-Lista, E. Vega-Martín, D. González-Moreno, M. Alcalá, M. Gil-Ortega, B. Somoza, C. Pizzamiglio, L.M. Ruilope, I. Aránguez, P. Kolkhof, R. Kreutz, M.S. Fernández-Alfonso
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115661- (2023)
The non-steroidal mineralocorticoid receptor antagonist (MRA) finerenone (FIN) improves kidney and cardiovascular outcomes in patients with chronic kidney disease (CKD) in type 2 diabetes (T2D). We explored the effect of FIN in a novel model of type
Externí odkaz:
https://doaj.org/article/587d3d659d0b4bd4b2787136fc4a2583
Autor:
P Ruiz Briones, V Escudero Vilaplana, R Collado Borell, J Vicente Valor, C Villanueva Bueno, A Narrillos Moraza, B Somoza Fernández, S Herrero Bermejo, D Gomez Costas, A Herranz Alonso, M Sanjurjo Saez
Publikováno v:
Late breaking abstracts.
Autor:
B Somoza-Fernández, A Ribed-Sánchez, S Martín-Lozano, FM de Vega-San Vicente, R Menéndez-Tarín, Á Giménez-Manzorro, P Sanz-Ruiz, I Garutti-Martínez, A Herranz-Alonso, J Vaquero-Martín, M Sanjurjo-Sáez
Publikováno v:
Injury. 53(12)
Enhanced Recovery After Surgery (ERAS) protocols and educational programmes have been shown to accelerate orthopaedic surgery recovery with fewer complications, and improve patient-reported outcomes (PROs) for different types of surgery. The objectiv
Autor:
B Somoza, A Ribed, S Martín, RM Menéndez, FM Vega, Á Giménez, Á Narrillos, A Herranz, M Sanjurjo
Publikováno v:
Section 5: Patient safety and quality assurance.
Autor:
M. Gil-Ortega, M. Martín-Ramos, S. Arribas, M. González, I. Aránguez, M Ruiz-Gayo, M. Fernández-Alfonso, B. Somoza
Publikováno v:
Artery Research, Vol 8, Iss 4 (2014)
Externí odkaz:
https://doaj.org/article/93fdb7f502dc40c085e61c7cac818b60
Autor:
C Villanueva Bueno, A Melgarejo Ortuño, B Somoza Fernandez, J Vicente Valor, FJ Garcia Moreno, C Rodriguez Gonzalez, E Chamorro de Vega, A. De Lorenzo Pinto, I Taladriz Sender, M Sanjurjo Sáez, A Herranz Alonso
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Identification of the angiotensin converting enzyme (ACE2) as a target of the SARS-CoV-2 virus raises questions about a possible change in the clinical course of this infection associated with inhibitors of the renin-angiote
Autor:
A. De Lorenzo Pinto, A Castuera Gil, A Herranz Alonso, M Sanjurjo Sáez, I Miguens Blanco, R. García Sánchez, C Ortega Navarro, B Somoza
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Flecainide is commonly used for conversion of recent onset ( Aim and objectives To evaluate successful cardioversion in patients treated with vernakalant or oral flecainide with recent onset AF attending the ED. Material and
Autor:
C Rodriguez Gonzalez, E Chamorro de Vega, J Vicente Valor, P Ruiz Briones, M Olmedo Samperio, B Somoza Fernandez, Pernia López, A Herranz Alonso, Á Narrillos Moraza, M Sanjurjo Sáez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Oral vancomycin (125 mg four times daily) is the standard treatment for mild/moderate Clostridium difficile infection (CDI). As there are no marketed vancomycin capsules in our country, vancomycin 500 mg vials have been take
Autor:
Bermejo, S. Herrero, Matilla, E. Lobato, Costas, D. Gómez, Fernández, B. Somoza, Briones, P. Ruiz, Villanueva, M. Ferris, Antón, M. D. P. Montero, Díez, Y. Rioja, Burdallo, A. Carrillo, Alonso, A. Herranz, Sáez, M. Sanjurjo
Publikováno v:
European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA144-A145, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.